NNovo Nordisk Read More Novo Nordisk Faces a Legal Double Header as Earnings Approach2026-07-30 The Danish pharmaceutical heavyweight is fighting on two legal fronts just days before a pivotal earnings report, with…
NNovo Nordisk Read More Novo Nordisk Faces a Double Squeeze: Lilly’s Record-Breaking Data and a High-Stakes Court Date2026-07-25 Eli Lilly has thrown down a fresh gauntlet in the GLP-1 arms race, unveiling late-stage data that shows…
NNovo Nordisk Read More Novo Nordisk’s Pill Strategy Gets a Double Boost – EU Nod and Analyst Upgrade – Yet the Growth S2026-07-21 Novo Nordisk shares have recouped more than 40% from their early-March low, but the stock still sits nearly…
BBerlin Read More Berlin’s Plan to Double Maximum Fixed-Term Contracts Sparks ‘Throwaway Jobs’ Fury2026-07-21 Berlins, Plan Published on 07/21/2026 at 02:42 | Redaktion boerse-global.de Germany…
NNovo Nordisk Read More Novo Nordisk’s Pill and Medicare Double Act Fails to Silence Analyst Doubts2026-07-05 A dual catalyst – the UK launch of an oral version of Wegovy and a fresh US Medicare…
BBerlin Read More Serena Williams pivots quickly to new playing partner for Berlin Open2026-06-11 Serena Williams opted to let Nike break the news about her pro tennis comeback at age 44 in…
NNovo Nordisk Read More Novo Nordisk’s Double Play: Digital Authority Meets Clinical Depth as Semaglutide’s Reach Widens2026-05-21 Wegovy tops AI searches; semaglutide shows 63% MASH resolution; oral pill gains momentum. Novo Nordisk faces mixed Q1…
NNovo Nordisk Read More Novo Nordisk Sheds Stray Assets to Double Down on Obesity Pipeline as Oral Wegovy Gains Traction2026-05-14 Novo Nordisk offloads Parkinson’s cell therapy to focus on obesity and diabetes, with CagriSema pending US approval and…
NNovo Nordisk Read More Novo Nordisk Tightens Operations as Oral Wegovy Pill Sales Double Expectations2026-05-13 Q1 revenue surged 32% as Wegovy oral sales beat forecasts 2x, but Novo Nordisk halts Odense production, cutting…
NNovo Nordisk Read More Fat-Loss Data Impress as Oral Wegovy Sales Double Expectations2026-05-13 Novo Nordisk unveils STEP UP trial data showing 84% fat loss and 27.7% weight reduction in early responders;…
NNovo Nordisk Read More FDA Curbs Copycats as Ozempic Pill Replaces Rybelsus2026-05-01 Novo Nordisk gains nearly 5% as FDA targets copycat weight-loss drugs and rebrands Rybelsus as the ‘Ozempic pill’…
BBerlin Read More Marion Local falls in double overtime thriller to Berlin Hiland in Division VI state final | Sports2026-03-22 DAYTON, Ohio (WLIO) — The Marion Local Flyers came up just short in a heartbreaker against Berlin Hiland…